Takeda to sell stake in Chinese JV | The Pharma Letter

Japanese pharma major Takeda (TYO: 4502) is to sell its majority share in Guangdong Techpool Bio-Pharma.

Techpool is a joint venture (JV) that Takeda has held a 51.34% stake in, with a focus on the research, discovery and marketing of urinary protein biopharmaceuticals and production of biopharmaceuticals in critical care.

@ The Pharma Letter | May 22, 2018